Vijaya Diagnostic Centre Ltd IPO

Closed

IPO Details

  • Open Date 01-Sep-21
  • Close Date 03-Sep-21
  • Lot Size 28
  • IPO Size ₹ 1,862.92 - 1,895.04 Cr
  • IPO Price Range ₹ 522 - 531
  • Min Investment ₹ 14,616
  • Listing Exchange NSE, BSE
  • Basis of Allotment 08-Sep-21
  • Refunds 09-Sep-21
  • Credit to Demat Account 13-Sep-21
  • Listing Date 14-Sep-21

Vijaya Diagnostic Centre Ltd IPO Subscription Status

Vijaya Diagnostic IPO Subscription Status

Category

Subscription Status
Qualified Institutional (QIB) 13.07 Times
Non-Institutional (NII) 1.32 Times
Retail Individual 1.09 Times
Employee 0.98 Times
Total 4.54  Times

 

Vijaya Diagnostic IPO Subscription Details (Day by Day)

 

Date QIB NII Retail Employee Total
September 01, 2021 17:00 0.23x 0.01x 0.46x 0.24x 0.30x
September 02, 2021 17:00 0.32x 0.05x 0.74x 0.52x 0.47x
September 03, 2021 17:00 13.07x 1.32x 1.09x 0.98x 4.54x

IPO Synopsis

Offer Details

The offer comprises of an offer for sale of ₹1,895cr. The objects of the Offer are to carry out the Offer for Sale of up to 35,688,064 Equity Shares by Selling Shareholders; achieve the benefits of listing the Equity Shares on the Stock Exchanges.

 

Vijaya Diagnostics Shareholding

% Shareholding

Pre- IPO(%)

Post-IPO(%)

Promoter & Promoter Group

59.78

54.78

Public

40.22

45.22

 

 

About Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre Limited offers a one-stop solution for pathology and radiology testing services to its customers through the extensive operational network, which consists of 81 diagnostic centres and 11 reference laboratories across 13 cities and towns in the states of Telangana & Andhra Pradesh, the National Capital Region and Kolkata as on June 30, 2021. The company offers a comprehensive range of approximately 740 routine and 870 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests, that cover a range of specialties and disciplines.

Vijaya Diagnostic Centre - Financials

 

(`₹ in crore)

FY19

FY20

FY21

Revenue from Operations

292.5

338.8

376.7

Adjusted EBITDA

108.1

132.6

165.9

EBITDA Margin (%)

37%

39%

44%

PAT

46.2

62.5

84.9

PAT Margin (%)

16%

18%

22%

Source: RHP


Competitive Strengths:

Some of the competitive strengths are as follows

1.  Largest and fastest-growing diagnostic chain with dominant position in south India 

Vijaya Diagnostic center is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chains by revenue for the fiscal year 2020 (Source: CRISIL Report). The company has built an extensive operational network consisting of 81 diagnostic centers including a flagship center located at Hyderabad, and 11 co-located reference laboratories, including a national reference laboratory at their flagship diagnostic center, across 13 cities and towns in the states of Telangana and Andhra Pradesh and in National Capital Region and Kolkata, as of June 30, 2021. For the fiscal year 2021, the company derived 86.21% and 9.99% of revenue from operations from Telangana and Andhra Pradesh, respectively.

2.  Well-positioned to leverage the high growth in the Indian diagnostics industry

According to the CRISIL Report, the Indian diagnostics market was valued at ~₹710 billion to ₹730 billion in the fiscal year 2021, and is projected to grow at CAGR of around 12% to 13% to reach ~₹920 billion to ₹980 billion by fiscal year 2023 driven by rise in health awareness and disposable incomes, increase in demand for better healthcare facilities and quality of care of individuals, and increase in spending on preventive and wellness. The combination of Vijaya Diagnostic’s strong brand position driven by the long operating history in their core geographies, their extensive operational network and their reputation for providing quality diagnostic services positions them well to continue to grow the scale of their business in Telangana and Andhra Pradesh market and take advantage of growing Indian diagnostic market.

3.  Integrated diagnostics provider that offers a one-stop solution

Vijaya Diagnostic Centre offers a comprehensive range of approximately 1,610 pathology tests, which are organized into approximately 740 routine tests and 870 specialized tests, as well as approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines, as of June 30, 2021. The company’s test menu includes (i) pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, including protein chemistry, cellular immunology, flow cytometry, genetics, cytogenetics, immunohistochemistry and advanced microbiology tests, and (ii) radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests such as MRI, HRCT, SPECT and PET CT. Given the focus on the provision of integrated diagnostic services, Vijaya Diagnostic Centre has provided 2.8 tests per customer on the average fiscal year in fiscal year2020, which is higher than other listed regional/multi-regional diagnostic chains, according to the CRISIL Report. 

Risk Factors:

Some of the risk factors are as follows
1.    The business operations are concentrated in South India, and any loss of business in such a region could have an adverse effect on their business.
2.    Failure or malfunction of their equipment could adversely affect their ability to conduct their operations.
3.    The company may become subject to professional malpractice liability claims, which could be costly and, therefore, could negatively affect their business.

 

Vijaya Diagnostic Centre Limited 5paisa Review
 

Considering the future growth potential of healthcare industry, debt free company with plans for acquisition and expansions, diversified service offerings and strong technical capabilities of the company, we recommend ‘Subscribe’ to the issue with a long-term perspective.

How to apply for IPO?

  • Login to your 5paisa account and select the issue in the current IPO section

  • Enter the number of lots and price at which you wish to apply for

  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange

  • You will receive a mandate notification to block funds in your UPI app

  • Approve the mandate request on your UPI and funds will be blocked

Contact Details of Vijaya Diagnostic Centre Ltd IPO

Contact Information

Vijaya Diagnostic Centre Limited
3-6-16 & 17, Street No. 19, Himayatnagar
Hyderabad, 500 029

Phone: +91 40 2342 0411
Email: ir@vijayadiagnostic.in
Website: https://www.vijayadiagnostic.com/

Vijaya Diagnostic Centre Ltd IPO Register

KFintech Private Limited
 KFintech, Tower-B, Plot No 31 & 32,
 Financial District, Nanakramguda, Gachibowli,
 Hyderabad, Telangana India - 500 032.

Phone: 04067162222, 04079611000
Email: vijaya.ipo@kfintech.com
Website: https://karisma.kfintech.com/

Vijaya Diagnostic Centre Ltd IPO Lead Manager

  • Edelweiss Financial Services Ltd
  • ICICI Securities Limited
  • Kotak Mahindra Capital Company Limited

IPO NewsIPO News

Top Stories for you
Story Blog
Trust Fintech IPO Subscribed 108.63 times

Trust Fintech IPO is book-built issue of ₹63.45 crores, consisting entirely of fresh issue shares totalling 62.82 lakh. Trust Fintech IPO commenced its subscription period on March 26, 2024, & concludes today, March 28, 2024. Allotment is scheduled for Tuesday, April 2, 2024, with listing on NSE SME tentatively set for Thursday, April 4, 2024.

Most Popular
Story Blog
Aspire & Innovative IPO Subscribed 15.17 times
Blue Pebble IPO Subscribed 56.32 times
SRM Contractors IPO Subscribed 86.56 times

IPO BlogIPO Blog

Top Stories for you
Naman In-Store (India) IPO Allotment Status

Building blocks of the Naman In-Store (India) Ltd IPO Naman In-Store (India) IPO is book built issue of Rs 25.35 crores. It consists entirely of fresh issue of 28.48 lakh shares. Naman In-Store (India) IPO opens for subscription on March 22, 2024, & closes on March 27, 2024. allotment is expected to be finalized on March 28, 2024. Naman In-Store (India) IPO will list on NSE SME with tentative listing date set ...

IPO GuideIPO Guide

Top Stories for you
IPO Cycle

The IPO cycle, also referred to as Initial Public Offering Cycle, allows private companies to go public and offer the company's shares to the general public for the first time. It ...

 
Greenshoe Option
How To Cancel An IPO Application
NFO vs IPO
What Is FPO In Share Market?
What is an Abridged Prospectus?
How to Buy IPO Online in India